O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 4.07 HKD -1.21% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
OrbusNeich Medical Group Holdings Ltd?
Write Note

Intrinsic Value

The intrinsic value of one OrbusNeich Medical Group Holdings Ltd stock under the Base Case scenario is 4.35 HKD. Compared to the current market price of 4.07 HKD, OrbusNeich Medical Group Holdings Ltd is Undervalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.35 HKD
Undervaluation 6%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation Backtest
OrbusNeich Medical Group Holdings Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OrbusNeich Medical Group Holdings Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OrbusNeich Medical Group Holdings Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about OrbusNeich Medical Group Holdings Ltd

Provide an overview of the primary business activities
of OrbusNeich Medical Group Holdings Ltd.

What unique competitive advantages
does OrbusNeich Medical Group Holdings Ltd hold over its rivals?

What risks and challenges
does OrbusNeich Medical Group Holdings Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OrbusNeich Medical Group Holdings Ltd.

Provide P/S
for OrbusNeich Medical Group Holdings Ltd.

Provide P/E
for OrbusNeich Medical Group Holdings Ltd.

Provide P/OCF
for OrbusNeich Medical Group Holdings Ltd.

Provide P/FCFE
for OrbusNeich Medical Group Holdings Ltd.

Provide P/B
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/S
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/GP
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/EBITDA
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/EBIT
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/OCF
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/FCFF
for OrbusNeich Medical Group Holdings Ltd.

Provide EV/IC
for OrbusNeich Medical Group Holdings Ltd.

Show me price targets
for OrbusNeich Medical Group Holdings Ltd made by professional analysts.

What are the Revenue projections
for OrbusNeich Medical Group Holdings Ltd?

How accurate were the past Revenue estimates
for OrbusNeich Medical Group Holdings Ltd?

What are the Net Income projections
for OrbusNeich Medical Group Holdings Ltd?

How accurate were the past Net Income estimates
for OrbusNeich Medical Group Holdings Ltd?

What are the EPS projections
for OrbusNeich Medical Group Holdings Ltd?

How accurate were the past EPS estimates
for OrbusNeich Medical Group Holdings Ltd?

What are the EBIT projections
for OrbusNeich Medical Group Holdings Ltd?

How accurate were the past EBIT estimates
for OrbusNeich Medical Group Holdings Ltd?

Compare the revenue forecasts
for OrbusNeich Medical Group Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OrbusNeich Medical Group Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OrbusNeich Medical Group Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of OrbusNeich Medical Group Holdings Ltd compared to its peers.

Compare the P/E ratios
of OrbusNeich Medical Group Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing OrbusNeich Medical Group Holdings Ltd with its peers.

Analyze the financial leverage
of OrbusNeich Medical Group Holdings Ltd compared to its main competitors.

Show all profitability ratios
for OrbusNeich Medical Group Holdings Ltd.

Provide ROE
for OrbusNeich Medical Group Holdings Ltd.

Provide ROA
for OrbusNeich Medical Group Holdings Ltd.

Provide ROIC
for OrbusNeich Medical Group Holdings Ltd.

Provide ROCE
for OrbusNeich Medical Group Holdings Ltd.

Provide Gross Margin
for OrbusNeich Medical Group Holdings Ltd.

Provide Operating Margin
for OrbusNeich Medical Group Holdings Ltd.

Provide Net Margin
for OrbusNeich Medical Group Holdings Ltd.

Provide FCF Margin
for OrbusNeich Medical Group Holdings Ltd.

Show all solvency ratios
for OrbusNeich Medical Group Holdings Ltd.

Provide D/E Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide D/A Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide Interest Coverage Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide Altman Z-Score Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide Quick Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide Current Ratio
for OrbusNeich Medical Group Holdings Ltd.

Provide Cash Ratio
for OrbusNeich Medical Group Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for OrbusNeich Medical Group Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for OrbusNeich Medical Group Holdings Ltd?

What is the current Free Cash Flow
of OrbusNeich Medical Group Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for OrbusNeich Medical Group Holdings Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
OrbusNeich Medical Group Holdings Ltd

Balance Sheet Decomposition
OrbusNeich Medical Group Holdings Ltd

Current Assets 347.7m
Cash & Short-Term Investments 246.7m
Receivables 37.6m
Other Current Assets 63.4m
Non-Current Assets 67.7m
Long-Term Investments 15.6m
PP&E 25.2m
Intangibles 22.3m
Other Non-Current Assets 4.6m
Current Liabilities 35.9m
Accounts Payable 6.2m
Accrued Liabilities 13.4m
Short-Term Debt 4.2m
Other Current Liabilities 12m
Non-Current Liabilities 6.8m
Long-Term Debt 2.4m
Other Non-Current Liabilities 4.4m
Efficiency

Earnings Waterfall
OrbusNeich Medical Group Holdings Ltd

Revenue
151.4m USD
Cost of Revenue
-47.4m USD
Gross Profit
104m USD
Operating Expenses
-71.4m USD
Operating Income
32.6m USD
Other Expenses
6.1m USD
Net Income
38.7m USD

Free Cash Flow Analysis
OrbusNeich Medical Group Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

OrbusNeich Medical Group Holdings Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Net Income
Positive Operating Income
62/100
Profitability
Score

OrbusNeich Medical Group Holdings Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

OrbusNeich Medical Group Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

OrbusNeich Medical Group Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
OrbusNeich Medical Group Holdings Ltd

Wall Street analysts forecast OrbusNeich Medical Group Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 5.2 HKD with a low forecast of 4.75 HKD and a high forecast of 5.78 HKD.

Lowest
Price Target
4.75 HKD
17% Upside
Average
Price Target
5.2 HKD
28% Upside
Highest
Price Target
5.78 HKD
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OrbusNeich Medical Group Holdings Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for OrbusNeich Medical Group Holdings Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

OrbusNeich Medical Group Holdings Ltd

Country

Hong Kong

Industry

Health Care

Market Cap

3.4B HKD

Dividend Yield

2.46%

Description

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Contact

Units 303 and 305, 3/F, Building 20E, Hong Kong Science Park, Shatin, New Territories
+85228022288
orbusneich.com

IPO

2022-12-23

Employees

880

Officers

Chairman of the Board & CEO
Mr. David Chien
CFO, Company Secretary & Executive Director
Mr. Wing Shing Chen
COO & Executive Director
Ms. Kwai Ching Lau
Chief Commercial Officer
Mr. Alain Djamel Khair

See Also

Discover More
What is the Intrinsic Value of one OrbusNeich Medical Group Holdings Ltd stock?

The intrinsic value of one OrbusNeich Medical Group Holdings Ltd stock under the Base Case scenario is 4.35 HKD.

Is OrbusNeich Medical Group Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 4.07 HKD, OrbusNeich Medical Group Holdings Ltd is Undervalued by 6%.

Back to Top